|  Sign up!  


Return to Course Listing



CME: Therapeutic Updates and Best Practices in the Treatment of Major Depressive Disorders (MDD)


Program Description / Statement of Need:

In this online CME self-learning program:

Major depressive disorder (MDD) is a major public health burden.  Based on the National Comorbidity Survey data using the Composite International Diagnostic Interview, the estimated risk of MDD over any given 12-month period is 6.6% (13.1 – 14.2 million U.S. adults), with an estimated lifetime risk of 16.2% (32.6 – 35.1 millions US adults).  Another estimate, from a recent wave of the National Health and Nutrition Examination Survey, indicates that 17.53% of men and 25.52% of women across all ages report having experienced depressive symptoms in the past.  Unfortunately, 58.8% of adults with symptoms classified as moderate and 36.9% of adults with symptoms classified as severe neither saw mental health professional nor received pharmacological treatment, suggesting a gap between present and optimal treatment of MDD. 


MDD is treatable and optimally involves a blend of appropriate medical resources, high-quality depression treatment programs and regimens, a collaboration of all persons responsible for the well-being of the patient, and educational programs supportive of those aspects of care.  This program has been designed to bring healthcare professionals’ knowledge up to date with the currently best and recommended practices in treating MDD.



Epidemiology and risk factors for MDD
Symptomology and diagnosis of MDD
Treatment in patients with MDD
Barrier to optimal care in patients with MDD
Summary and best practices


Target Audience:

Healthcare professionals specializing in: family practice, internal medicine, mental health, pediatric or adult psychiatry, or those who otherwise commonly care for patients with major depressive disorder or related psychiatric diseases.

Program Objectives:

By the end of the session the participant will be able to:

    • Describe the challenges associated with diagnosis of MDD.
    • Describe the challenges associated with treating patients with MDD.
    • Apply existing diagnostic recommendations and criteria to practice in the management of MDD.
    • Identify the present treatment options currently available for management of MDD and apply them to patient cases using evidence-based medicine
    • Evaluate a treatment plan for a specific patient based on degree of MDD to optimize safety and efficacy, suggesting modifications for improvement.


    This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.


    Credit Designation: ScientiaCME designates this educational activity for a maximum of .75 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Release Date: August 06, 2012
    Expiration Date: August 06, 2014

    Faculty: Sarah Grady PharmD

    Faculty Disclosure and Resolution of COI:

     As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved through  content review ScientiaCME.


    Faculty Disclosure: Sarah Grady, PharmD has no relevant financial disclosures..


    Disclosures of Educational Planners:


    Steven Sachse is an officer and part owner of ScientiaCME, LLC, which has received a grant from the commercial supporter of this program: Eli Lilly and Company.

    Charles Turck, PharmD, is an officer and part owner of ScientiaCME, LLC which has received grants from  the commercial supporter of this program: Eli Lilly and Company.


    Commercial Support Disclosure: This program is supported by an educational grant from Eli Lilly and Company.


    Unlabled Use Disclosure: This program may contain off-label and/or investigational uses of commercial products.


    Viewing Requirements:



    Windows 2000 or above
    Internet Explorer 5.5
    Adobe Acrobat Reader*

    Mac OS 10.2.8
    Adobe Acrobat Reader*
    Internet Explorer is not supported on the Macintosh


    *Required to view Printable PDF Version


    Privacy Policy



    -Read the learning objectives and faculty disclosures above

    -Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowedge gained by participating in this CME activity.

    -View the on-line program. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.

    -Take the post-test

    -Complete the program evaluation and CME registration. A CE certificate will be emailed to you.

    Perform Pre-Test (optional)
    Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.

    Download the Presentation (optional)


    View the online program


    Perform Post-Test

    Complete the Symposium Evaluation and Request CE Certificate

This program is supported by Educational Grants from Eli Lilly and Company.


Your feedback is important to us. Please Contact Us to let us know how to make this site better. Thank you.